237 related articles for article (PubMed ID: 32559308)
1. Haematological cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date.
El-Sharkawi D; Iyengar S
Br J Haematol; 2020 Aug; 190(3):336-345. PubMed ID: 32559308
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Passamonti F; Cattaneo C; Arcaini L; Bruna R; Cavo M; Merli F; Angelucci E; Krampera M; Cairoli R; Della Porta MG; Fracchiolla N; Ladetto M; Gambacorti Passerini C; Salvini M; Marchetti M; Lemoli R; Molteni A; Busca A; Cuneo A; Romano A; Giuliani N; Galimberti S; Corso A; Morotti A; Falini B; Billio A; Gherlinzoni F; Visani G; Tisi MC; Tafuri A; Tosi P; Lanza F; Massaia M; Turrini M; Ferrara F; Gurrieri C; Vallisa D; Martelli M; Derenzini E; Guarini A; Conconi A; Cuccaro A; Cudillo L; Russo D; Ciambelli F; Scattolin AM; Luppi M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Olivieri A; Bocchia M; Gentile M; Marchesi F; Musto P; Federici AB; Candoni A; Venditti A; Fava C; Pinto A; Galieni P; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Visco C; Franchi M; Grossi PA; Bertù L; Corrao G; Pagano L; Corradini P;
Lancet Haematol; 2020 Oct; 7(10):e737-e745. PubMed ID: 32798473
[TBL] [Abstract][Full Text] [Related]
3. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 in persons with haematological cancers.
He W; Chen L; Chen L; Yuan G; Fang Y; Chen W; Wu D; Liang B; Lu X; Ma Y; Li L; Wang H; Chen Z; Li Q; Gale RP
Leukemia; 2020 Jun; 34(6):1637-1645. PubMed ID: 32332856
[TBL] [Abstract][Full Text] [Related]
5. Managing patients with hematological malignancies during COVID-19 pandemic.
Sahu KK; Cerny J
Expert Rev Hematol; 2020 Aug; 13(8):787-793. PubMed ID: 32580592
[No Abstract] [Full Text] [Related]
6. COVID-19 and haematological malignancy: navigating a narrow strait.
Rubinstein SM; Warner JL
Lancet Haematol; 2020 Oct; 7(10):e701-e703. PubMed ID: 32798474
[No Abstract] [Full Text] [Related]
7. Balancing risk and benefit during coronavirus.
Sehn LH
Blood; 2020 May; 135(21):1817. PubMed ID: 32275744
[No Abstract] [Full Text] [Related]
8. Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy.
Percival MM; Lynch RC; Halpern AB; Shadman M; Cassaday RD; Ujjani C; Shustov A; Tseng YD; Liu C; Pergam S; Libby EN; Scott BL; Smith SD; Green DJ; Gopal AK; Cowan AJ
JCO Oncol Pract; 2020 Sep; 16(9):571-578. PubMed ID: 32369409
[TBL] [Abstract][Full Text] [Related]
9. Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.
Shoumariyeh K; Biavasco F; Ihorst G; Rieg S; Nieters A; Kern WV; Miething C; Duyster J; Engelhardt M; Bertz H
Cancer Med; 2020 Nov; 9(22):8412-8422. PubMed ID: 32931637
[TBL] [Abstract][Full Text] [Related]
10. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Weinkove R; McQuilten ZK; Adler J; Agar MR; Blyth E; Cheng AC; Conyers R; Haeusler GM; Hardie C; Jackson C; Lane SW; Middlemiss T; Mollee P; Mulligan SP; Ritchie D; Ruka M; Solomon B; Szer J; Thursky KA; Wood EM; Worth LJ; Yong MK; Slavin MA; Teh BW
Med J Aust; 2020 Jun; 212(10):481-489. PubMed ID: 32401360
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies.
Molica M; Mazzone C; Cordone I; Pasquale A; Niscola P; de Fabritiis P
Br J Haematol; 2020 Jul; 190(1):e5-e8. PubMed ID: 32369605
[No Abstract] [Full Text] [Related]
12. Strategic plan for management of COVID-19 in paediatric haematology and oncology departments.
He Y; Lin Z; Tang D; Yang Y; Wang T; Yang M
Lancet Haematol; 2020 May; 7(5):e359-e362. PubMed ID: 32246912
[No Abstract] [Full Text] [Related]
13. Reply to "COVID-19 in persons with haematological cancers": a focus on myeloid neoplasms and risk factors for mortality.
Fattizzo B; Giannotta JA; Sciumè M; Cattaneo D; Bucelli C; Fracchiolla NS; Onida F; Baldini L; Barcellini W; Iurlo A
Leukemia; 2020 Jul; 34(7):1957-1960. PubMed ID: 32457356
[No Abstract] [Full Text] [Related]
14. Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit - High mortality rate in infected patients with haematologic malignancies.
Biernat MM; Zińczuk A; Biernat P; Bogucka-Fedorczuk A; Kwiatkowski J; Kalicińska E; Marciniak D; Simon K; Wróbel T
J Clin Virol; 2020 Sep; 130():104574. PubMed ID: 32769026
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.
Cattaneo C; Daffini R; Pagani C; Salvetti M; Mancini V; Borlenghi E; D'Adda M; Oberti M; Paini A; De Ciuceis C; Barbullushi K; Cancelli V; Belotti A; Re A; Motta M; Peli A; Bianchetti N; Anastasia A; Dalceggio D; Roccaro AM; Tucci A; Cairoli R; Muiesan ML; Rossi G
Cancer; 2020 Dec; 126(23):5069-5076. PubMed ID: 32910456
[TBL] [Abstract][Full Text] [Related]
16. [SARS-CoV-2/COVID 19 Infection and Solid Cancers: Synthesis of Recommendations for Health Professionals].
Grellety T; Ravaud A; Canivet A; Ganem G; Giraud P; Guimbaud R; Kaluzinski L; Krakowski I; Mayeur D; Lotz JP; You B
Bull Cancer; 2020 Apr; 107(4):400-402. PubMed ID: 32229048
[No Abstract] [Full Text] [Related]
17. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.
Shah V; Ko Ko T; Zuckerman M; Vidler J; Sharif S; Mehra V; Gandhi S; Kuhnl A; Yallop D; Avenoso D; Rice C; Sanderson R; Sarma A; Marsh J; de Lavallade H; Krishnamurthy P; Patten P; Benjamin R; Potter V; Ceesay MM; Mufti GJ; Norton S; Pagliuca A; Galloway J; Kulasekararaj AG
Br J Haematol; 2020 Sep; 190(5):e279-e282. PubMed ID: 32526039
[No Abstract] [Full Text] [Related]
18. Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic.
Willan J; King AJ; Djebbari F; Turner GDH; Royston DJ; Pavord S; Collins GP; Peniket A
Br J Haematol; 2020 Jun; 189(6):e224-e227. PubMed ID: 32369622
[No Abstract] [Full Text] [Related]
19. [Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].
Kirova Y
Cancer Radiother; 2020 Jun; 24(3):194-195. PubMed ID: 32402596
[No Abstract] [Full Text] [Related]
20. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
